Literature DB >> 28357630

Age-structured population model of cell survival.

Wojciech Krzyzanski1, Pawel Wiczling2,3, Asfiha Gebre2,4.   

Abstract

Age-structured cell population model was introduced to describe cell survival. The impact of the environment on the cell population is represented by drug plasma concentration. A key model variable is the hazard of cell removal that is a subject to the environment effect. The model is capable of describing cohort and random labeling cell survival data. In addition, it accounts for cell loss due to labeling of cell sample, but it lacks ability to describe the effect of label elution on the survival data. The model was applied to red blood cell (RBC) survival data in two groups of Wistar rats obtained by two techniques: cohort labeling using 14C-glycine (N = 4) and random labeling using biotin (N = 8). The Weibull probability density function was selected for the RBC lifespan distribution. The data were simultaneously fitted by the mixed effects model implemented in Monolix 4.3.3. The estimated typical values of RBC lifespan and age were 53.7 and 27.8 days, respectively. A noticeable effect of biotinylation on RBC survival was observed that resulted in a significant difference between the means of individual RBC lifespan for two groups. The model provides a mechanistic framework flexible enough to account for various experimental designs to generate the cell survival data. Despite model qualification using animal data, the model has the same potential to be applied to cell survival data analysis in humans.

Entities:  

Keywords:  Age-structured population; Cell survival; Cohort labeling; Death hazard; Lifespan; Random labeling; Weibull function

Mesh:

Substances:

Year:  2017        PMID: 28357630     DOI: 10.1007/s10928-017-9520-6

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  15 in total

1.  Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation.

Authors:  Frans L A Willekens; Bregt Roerdinkholder-Stoelwinder; Yvonne A M Groenen-Döpp; Harry J Bos; Giel J C G M Bosman; Annegeet G van den Bos; Arie J Verkleij; Jan M Werre
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

2.  Evaluation of red blood cell labelling methods based on a statistical model for red blood cell survival.

Authors:  Julia Korell; Carolyn V Coulter; Stephen B Duffull
Journal:  J Theor Biol       Date:  2011-09-21       Impact factor: 2.691

3.  Modeling red blood cell survival data.

Authors:  Julia Korell; Frederiek E Vos; Carolyn V Coulter; John B Schollum; Robert J Walker; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-10-14       Impact factor: 2.745

4.  Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells.

Authors:  D M Mock; G L Lankford; J A Widness; L F Burmeister; D Kahn; R G Strauss
Journal:  Transfusion       Date:  1999-02       Impact factor: 3.157

Review 5.  Pharmacodynamic models of age-structured cell populations.

Authors:  Wojciech Krzyzanski
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-16       Impact factor: 2.745

6.  Modeling of red blood cell life-spans in hematologically normal populations.

Authors:  Rocío Lledó-García; Robert M Kalicki; Dominik E Uehlinger; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-07-31       Impact factor: 2.745

7.  Determination of erythrocyte life span in F-344, Wistar, and Sprague-Dawley rats using a modification of the [3H]diisopropylfluorophosphate ([3H]DFP) method.

Authors:  M J Derelanko
Journal:  Fundam Appl Toxicol       Date:  1987-08

8.  Post-synthetic modification in vivo of the major hemoglobin beta chain in the rat.

Authors:  L M Garrick; M L Chu; P Rusnak-Smalley; M D Garrick
Journal:  Hemoglobin       Date:  1987       Impact factor: 0.849

9.  A pharmacodynamic model of erythropoietin therapy for uremic anemia.

Authors:  D E Uehlinger; F A Gotch; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1992-01       Impact factor: 6.875

10.  Models for the red blood cell lifespan.

Authors:  Rajiv P Shrestha; Joseph Horowitz; Christopher V Hollot; Michael J Germain; John A Widness; Donald M Mock; Peter Veng-Pedersen; Yossi Chait
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-04-02       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.